Based on tissue expression, genome location and phloretin sensitivity, human NHA2 was proposed to be the candidate gene for the Na+(Li+) countertransport activity associated with the development of essential hypertension and diabetes in humans9–12. Here, SLC9B2 is linked to hypertensive disorder.